Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects.
Nalin
D R
DR
Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania.
D002939:Ciprofloxacin / Q000494:pharmacology; D004269:DNA, Bacterial / Q000187:drug effects; D004352:Drug Resistance, Microbial; D006801:Humans; D009154:Mutation; D009643:Norfloxacin / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology
D004269:DNA, Bacterial; D011804:Quinolines; D002939:Ciprofloxacin; D009643:Norfloxacin